Affinia Therapeutics

Affinia Therapeutics recognizes the importance of expanded access pathways for patients with serious or life-threatening conditions who have no satisfactory treatment options. Currently, Affinia does not have its investigational medicines available through expanded access, early access, managed access, or compassionate use programs in any region. Affinia believes that participating in clinical trials is the best way for patients to access investigational medicines.